Earnings Feed
Start Free
Home/Filings/4/0001140361-14-010996
4//SEC Filing

Opexa Therapeutics, Inc. 4

Accession 0001140361-14-010996

CIK 0001069308operating
View on SEC.govCompany Profile

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 5:35 PM ET

Size

10.0 KB

Accession

0001140361-14-010996

Insider Transaction Report

Form 4
Period: 2014-02-28
Opexa Therapeutics, Inc.OPXA
Seaman Scott B
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2014-02-28+17,686→ 17,686 total
    Exercise: $1.82Exp: 2024-02-28→ Common Stock (17,686 underlying)
  • Award

    Stock Option (Right to Buy)

    2014-02-28+5,896→ 5,896 total
    Exercise: $1.82Exp: 2024-02-28→ Common Stock (5,896 underlying)
  • Award

    Stock Option (Right to Buy)

    2014-02-28+8,844→ 8,844 total
    Exercise: $1.82Exp: 2024-02-28→ Common Stock (8,844 underlying)
Footnotes (3)
  • [F1]50% excercisable on grant date of February 28, 2014 and the balance vests on December 31, 2014.
  • [F2]50% excercisable on grant date of February 28, 2014 and the balance vests on February 28, 2015.
  • [F3]25% vests on each of March 31, 2014, June 30, 2014, September 30, 2014 and December 31, 2014.

Documents

1 file

Issuer

Opexa Therapeutics, Inc.

CIK 0001069308

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001069308

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:35 PM ET
Size
10.0 KB
View on SEC.gov